Precision Optics Corporation Financial Results
Precision Optics reported Q1 2027 revenue growth of 22% year-over-year to $8.2 million, driven by strong performance in satellite optical communications and single-use medical device programs. The company's net loss narrowed significantly to $0.5 million compared to $1.6 million in the prior year, while gross margins improved to 22.5%.
- Term
- Q1 2027
“Revenue grew 22% year over year to $8.2 million, led by a 23% increase in production revenue. Higher volumes and more efficient manufacturing helped lift gross margin and improved our Adjusted EBITDA.”
Dr. Joe Forkey, CEO of Precision Optics
“We continued to make operational progress with our single-use medical device programs. The cystoscope program generated $1.8 million in production revenue, and our ophthalmic program delivered revenue of $581,000, as shipments increased under its $3.5 million follow-on order.”
Dr. Joe Forkey, CEO of Precision Optics